Potassium Citrate Tablet, Extended Release
Product Images NDC 51407-451

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Potassium Citrate (NDC 51407-451). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-449-01ol.jpg (51407 449 01ol)

Each extended-release tablet contains 5 mEq (540 mg) of potassium citrate, USP as monohydrate. Each 5 mEq tablet is debossed with "536" on one side and plain on the other side. Potassium Citrate Extended-release Tablets USP, 5 mEq are dispensed in tight containers and should be kept at a controlled room temperature. This medication should be kept out of reach of children. Dosage information can be found in the accompanying Prescribing Information.*

FDA Label Image

51407-450-01ol.jpg (51407 450 01ol)

Potassium citrate extended-release tablets contain 10 mEq (1080 mg) of potassium citrate as monohydrate. Each 10 mEq tablet is oval-shaped and tan to yellowish in color, debossed with “5637” on one side and plain on the other. The dosage information is provided in the accompanying prescribing information. The tablets should be stored in a tight container at room temperature and kept out of reach of children. The package insert should be dispensed with the bottle. Cadila Healthcare Ltd. manufactures these tablets, and they are marketed by GSMS, Incorporated.*

FDA Label Image

51407-451-01ol.jpg (51407 451 01ol)

Potassium Citrate Extended-release Tablets are a medicine that contains 15 mEq (1620 mg) of potassium citrate for oral administration. These tablets are biconvex and come in a tan to yellowish color. The tablets are uncoated and have "5638" imprinted on one side and plain on the other side. It is dispensed in a tight container as defined in the USP and the package insert should be dispensed with the bottle. The tablets are stored between 20°C to 25°C (68° - 77 F), and should be kept out of the reach of children. Manufactured by Cadila Healthcare Ltd. and Marketed by GSMS, Incorporated. Refer to the accompanying Prescribing Information for dosage.*

FDA Label Image

7c1ad1a3 194b 4c50 Bd5e Ebf80ae568ae 01

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.